title: Influence of HLA-DRB1* incompatibility on the occurrence of rejection episodes and graft survival in serologically HLA-DR-matched renal transplant combinations.
abstract: BACKGROUND
  The aim of the present study was to analyze the effect of HLA-DRB1* mismatches on graft function and graft survival in 92 patients who received serologically HLA-DR split antigen-matched cadaveric renal transplants.
  
  
  METHODS
  The polymorphic second exon of the HLA-DRB1 alleles was typed using the sequence-specific oligonucleotides technique.
  
  
  RESULTS
  The results show that in 26 of the 92 analyzed combinations, one or more HLA-DRB1* mismatches were found (28%). The analysis of the occurrence of treatable rejection episodes during the first 3 months after transplantation demonstrated a significantly higher incidence of rejection episodes in the HLA-DRB1*-mismatched group: 18 of 26 (69%) in the HLA-DRB1*-mismatched group against 23 of 66 (35%) in the HLA-DRB1*-matched group (P(uncorr)=0.0033). However, no effect of HLA-DRB1* mismatches on graft survival was found, although in general graft survival in the whole patient group was negatively influenced by the occurrence of rejection episodes during the first 3 months after transplantation (P(uncorr)=0.0008). In contrast, in the HLA-DR4-matched donor-recipient combinations (n=28), the effect of mismatching for the HLA-DRB1*04 alleles seemed to have a pronounced effect not only on the occurrence of rejection episodes but also in the form of diminished graft survival.
  
  
  CONCLUSIONS
  Thus, this study indicates that the existence of HLA-DRB1* allele mismatches in renal transplant recipients, matched for the serologically defined HLA-DR split antigens, is not harmful for the transplant. The exception is the HLA-DRB1*04 mismatch, which seems to be deleterious for the grafted organ.
authors.affiliation: Department of HLA Diagnostics, Central Laboratory of the Netherlands Red Cross-Blood Transfusion Service, Amsterdam.
authors.forename: N M
authors.initials: NM
authors.lastname: Lardy
authors.forename: A R
authors.initials: AR
authors.lastname: van der Horst
authors.forename: I J
authors.initials: IJ
authors.lastname: ten Berge
authors.forename: S
authors.initials: S
authors.lastname: Surachno
authors.forename: J M
authors.initials: JM
authors.lastname: Wilmink
authors.forename: L P
authors.initials: LP
authors.lastname: de Waal
mesh_terms: D000483:Alleles; D001788:Blood Grouping and Crossmatching; D002102:Cadaver; D005006:Ethnicity / Q000235:genetics; D006084:Graft Rejection / Q000276:immunology; D006085:Graft Survival / Q000276:immunology; D015234:HLA-A Antigens / Q000276:immunology; D015235:HLA-B Antigens / Q000276:immunology; D006684:HLA-DR Antigens / Q000276:immunology*; D006648:Histocompatibility; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology
chemical_list: D015234:HLA-A Antigens; D015235:HLA-B Antigens; D006684:HLA-DR Antigens